Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
JSPR holding history
Jasper Therapeutics, Inc. in every 13F filed by Sphera Funds Management Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JSPR overviewAll 13F holders of JSPRFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −485,401−100.0% | Sold out | Holders |
| Q4 2025 | 485,401 | $888.3K | 0.2% | −144,069−22.9% | Reduced | Holders |
| Q3 2025 | 629,470 | $1.50M | 0.4% | +614,799+4,190.6% | Added | Holders |
| Q2 2025 | 14,671 | $81.4K | <0.1% | −107,346−88.0% | Reduced | Holders |
| Q1 2025 | 122,017 | $524.7K | 0.1% | −13,703−10.1% | Reduced | Holders |
| Q4 2024 | 135,720 | $2.90M | 0.5% | −53,550−28.3% | Reduced | Holders |
| Q3 2024 | 189,270 | $3.56M | 0.6% | −264,957−58.3% | Reduced | Holders |
| Q2 2024 | 454,227 | $10.3M | 1.7% | −51,015−10.1% | Reduced | Holders |
| Q1 2024 | 505,242 | $14.8M | 2.4% | −207,821−29.1% | Reduced | Holders |
| Q4 2023 | 713,063 | $5.63M | 1.0% | −4,974,071−87.5% | Reduced | Holders |
| Q3 2023 | 5,687,134 | $3.98M | 1.0% | +1,413,126+33.1% | Added | Holders |
| Q2 2023 | 4,274,008 | $5.86M | 1.3% | +230,000+5.7% | Added | Holders |
| Q1 2023 | 4,044,008 | $7.32M | 1.6% | +4,044,008 | New | Holders |